PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Lignende værker

• Cutaneous light chain amyloidosis with multiple myeloma: A concise review
  af: Mirela Andrei, et al.
  Udgivet: (2019-04-01)
• Role of reduced intensity conditioning in allogeneic hematopoietic cell transplantation for patients with multiple myeloma
  af: Taiga Nishihori, et al.
  Udgivet: (2011-01-01)
• RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA
  af: Ugo Testa, et al.
  Udgivet: (2024-06-01)
• MYC alterations in multiple myeloma: Genetic insights and prognostic impact
  af: Sara Cristóbal-Vargas, et al.
  Udgivet: (2025-08-01)
• Genomic Insights into Tumorigenesis in Newly Diagnosed Multiple Myeloma
  af: Marina Kyriakou, et al.
  Udgivet: (2025-08-01)